What You Should Know:
- PreferredOne teams with Pear to provide its members
with covered access to two prescription digital therapeutics (PDTs) for the
treatment of substance use disorder (SUD) and opioid use disorder (OUD)
- PDTs are a new therapeutic class that uses software to
directly treat disease. Like traditional medicines, PDTs are tested in
randomized controlled trials demonstrating safety and effectiveness, evaluated
and authorized by regulators like FDA, and used under the
Read More
Digital Therapeutics | Digital Health | Evidence-Based Therapeutics Interventions
Medisafe Launches New Platform for Medication Management to Improve Patient Journey
What You Should Know:
- Medisafe launches a new Medisafe Maestro platform that brings precision and speed to patient journeys.
- The new platform aims to revolutionize digital health platforms by combining a host of resources to help patients through any hurdle in their journey and updates and monitoring happen in real-time to meet patients in their moments.
Medisafe, a Boston,
MA-based digital therapeutics companion platform, announced the immediate
deployment of its new Medisafe
Read More
How the Simple Telehealth Visit Will Revolutionize Care Delivery and Disease Management
Anthony Pannozzo, Chief Design Officer and Global Healthcare Lead at frog
The impact of COVID-19 on the healthcare industry’s ability to innovate has been stunning. We have seen FDA emergency authorizations and relaxed regulatory guidelines enable the development of radical new ventilator ideas, accelerated timelines for vaccine development, and an extraordinary transition to telehealth services. Many of these actions were a response to the exposure of weak spots in our healthcare system, but
Read More
Biofourmis Lands $100M to Expand AI-Powered Digital Therapeutics Platform
What You Should Know:
- Boston-based digital therapeutics leader Biofourmis
just closed a $100 million Series C funding round led by SoftBank,
bringing its total funding to $145M.
- Biofourmis will be using the funding to develop, validate and commercialize several released and unreleased digital therapeutics solutions across cardiology, oncology, respiratory, and pain, with a focus on the United States and key Asian markets, including Asia Pacific, China, and
Read More
Digital Therapeutics Company DarioHealth Raises $28M to Expand Market Share
What You Should Know:
DarioHealth raises $28M in institutional financing
intended to finance growth of their digital therapeutics B2B market share with
employers, health insurance plans, and healthcare providers.
The company sold 2,969,266 shares of common stock and, to
certain investors in lieu thereof, pre-funded warrants to purchase 824,689
shares of common stock at an exercise price of $0.0001 per share.
DarioHealth Corp.
(Nasdaq: DRIO), a pioneer in the global digital therapeutics
Read More
DarioHealth, Williams Medical Partner to Expand Digital Therapeutics Platform Across the UK and Ireland
What You Should Know:
- Dario Health enters strategic partnership with Williams
Medical marking its expansion into the UK remote patient monitoring market across
the UK and Ireland.
- Williams Medical is the leading provider of medical
goods and services to primary care in the UK, and this agreement supports both
companies' commitment to drive growth and deliver innovative solutions to
frontline healthcare.
DarioHealth Corp., a
pioneer in the global digital therapeutics market,
Read More
10 Healthcare Innovations That Can Reduce Total Disease Burden 6-10% by 2040
What You Should Know:
- 40 percent of
the global disease burden could be addressed with known interventions, but that
leaves 60 percent unaddressed.
- As part of the recent McKinsey report Prioritizing
health: A prescription for prosperity, the McKinsey Global Institute identified
ten promising innovations that can reduce total disease burden 6-10% by 2040.
- By identifying and estimating the potential scope of
innovations in the pipeline, we find that these technologies could
Read More
Scripps Research, Repurpose.AI Partner to Develop COVID-19 Therapeutics
What You Should Know:
- Repurpose.AI, has partnered with Scripps Research to
discover drug candidates that may be repurposed to treat COVID-19.
- The partnership will leverage Repurpose.AI's ActivPred
AI Drug Discovery Platform, an unbiased drug, target, and disease agnostic
digital chemistry engine, to discover drug candidates to treat COVID-19.
Scripps Research is
teaming up with Repurpose.AI, an AI
drug discovery company to develop COVID-19 therapeutics. The
Read More
Kaia Health Lands $26M to Expand AI-Driven Digital Therapeutics for MSK Conditions & COPD
What You Should Know:
- Digital therapeutics company Kaia Health raises $26M in
Series B funding to help grow its digital therapy solutions for musculoskeletal
(MSK) conditions, and expand into new conditions.
- The investment was led by Optum Ventures, Idinvest and
capital300, plus participation from Balderton Capital, Heartcore Capital and
Symphony Ventures, an investment partnership with world #1 golfer Rory McIlroy.
- Kaia Health’s smartphone-based
approach to managing chronic
Read More
5 Reasons Why Providers Need Electronic Support for Glycemic Management
Robby Booth, SVP of Research and Development at Glytec
It’s no secret hyperglycemia and hypoglycemia are associated with adverse outcomes in hospitalized patients. We’ve known for many years that hyperglycemia is widespread in the hospital, causes immune dysfunction, higher rates of infection, a longer length of hospital stay, complications, and even death.
Insulin has been the most effective therapy for hyperglycemia since it was first created almost 100 years ago, but it can also be
Read More
